A carregar...
Publicação
Probioxy: redefining the treatment landscape of inflammatory bowel disease - business model and company overview
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 925.58 KB | Adobe PDF |
Orientador(es)
Resumo(s)
ProbiOxy is a biopharma start-up with a vision to develop the first probiotic treat ment that effectively helps patients suffering from Inflammatory Bowel Disease relieve their
symptoms and experience a transformative shift in their quality of life. Its strategic approach
evolves around obtaining initial funding, licensing intellectual property, advancing through pre clinical and clinical trials, growing the patent portfolio, developing the product pipeline, and
ultimately exiting through acquisition by a prominent pharmaceutical entity. Other important
aspects of implementing such a business are key resources, operations, financial projections,
preparing and managing the acquisition, and having a contingency plan in place.
Descrição
Palavras-chave
Treatment Ibd Business model Company overview Science-based entrepreneurship Probiotics R&D Business risks Company roadmap Exit scenario Growth